Added to YB: 2025-06-27
Pitch date: 2025-06-26
CLPT [bullish]
ClearPoint Neuro, Inc.
-22.03%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$12.03
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
special_situation
ClearPoint Neuro Set to Benefit from Rare Disease Regulatory Revolution
CLPT added: Top pick in biotech due to FDA fast-tracking rare disease approvals, accelerating partner timelines. Reduced binary risk - like owning rare disease biotech ETF in one stock. Biotech assets priced for zero upside despite trials progressing in favorable FDA environment.
Read full article (1 min)